This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Endeavour Mining PLC | 1,720.0 | 4.2% |
| Fresnillo PLC | 747.4 | 3.5% |
| Severn Trent PLC | 2,824.0 | 2.1% |
| Convatec Group PLC | 220.6 | 1.8% |
| Admiral Group PLC | 1,912.0 | 1.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Standard Chartered PLC | 688.8 | -6.9% |
| Barclays PLC | 147.5 | -6.3% |
| Beazley PLC | 545.0 | -6.3% |
| Ashtead Group PLC | 5192.0 | -6.2% |
| Ocado Group PLC | 423.8 | -6.1% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,549 | -2.6% | 5.5% |
| DOW JONES INDUS. AVG | 31,819 | -0.3% | -3.4% |
| DAX INDEX | 14,959 | -3.0% | 9.8% |
| NIKKEI 225 | 27,833 | -1.1% | 10.0% |
| S&P/ASX 200 INDEX | 7,109 | -0.5% | -0.6% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 74.80 | -2.45% |
| Brent Crude (ICE) | USD/bbl. | 80.72 | -2.49% |
| Gold Spot | USD/t oz. | 1,914 | 2.4% |
| Copper (Comex) | USd/lb. | 405 | 0.6% |
Click graph to enlarge
The UK 100 called to open -11 points at 7537. The UK 100 is expected to extend its losses on Tuesday after the rout in banking shares continued in the US and extended into Asia. In Asia this morning shares of Japan’s biggest banks dropped sharply as global markets reacted to a US banking sector sell-off and uncertainty over interest rates in the wake of the collapse of Silicon Valley Bank. Japan’s Topix Banks index was down as much as 7.8%, on track for its worst day in more than three years, while the Topix fell more than 3.1%. The Nikkei 225 ended down 2.2% while the Hang Seng index in Hong Kong tumbled 2.4%. US markets were mixed Monday. The Dow closed Monday down 91 points or 0.3%, at 31,819, while the Nasdaq Composite added 50 points or 0.5%, to end the day at 11,189 while the S&P 500 lost 6 points, 0.2%, to close out the day at 3,856.
Close Brothers Group reports a H1 operating profit before tax of £11.7m, down 91% YoY from £128.9m. Their H1 impairment losses on financial assets were £162.2m, up from £48.3m YoY.
Computacenter says its 2022 performance is to be in line with January’s trading update.
GSK’s asthma drug Nucala has been accepted for review by China National Medial Products Admin.
Pennon says they are on track to deliver FY results in line with management expectations.
Sainsbury’s are to buy Supermarket Income’s 51% stake in Highbury, Dragon Inv vehicles for £430.9m. The transaction will result in Sainsbury’s acquiring the freehold of 21 stores.
TP ICAP reported a 370.8% surge in its annual profit underpinned by volatile trading in stocks and foreign exchange amid improving investor confidence. They reported a FY pretax profit of £113m for the year ended Dec 31st, compared with a profit of £24m last year.
RPT/Societe Generale Downgrades Ferguson to Hold from Buy (7 Buys / 8 Holds / 0 Sells)
UK
Close Brothers Group
Genuit Group
TP ICAP
UK
4Imprint Group
Balfour Beatty
Ferrexpo
Foresight Solor Fund
Marshalls
Prudential
US
Adobe
UK Claimant Count Change
EU EcoFin Meeting
US Consumer Price Index ex Food & Energy
BoJ Monetary Policy Meeting Minutes
UK 100 companies going ex-dividend on 16th March 2023:
M&G
NatWest Group
SEGRO
Anglo American
CRH
Haleon
UK 250 companies going ex-dividend on 16th March 2023:
Crest Nicholson Holdings
Dunelm Group
Spirent Communications
Bellevue Healthcare Trust
Digital 9 Infrastructure
abrdn Private Equity Opportunities Trust
JPMorgan Emerging Markets Invest Trust
Balanced Commercial Property Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.